Huxley SANSA Home Sleep Apnea Test (1000-00) vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Huxley SANSA Home Sleep Apnea Test (1000-00)
by Huxley Medical
VS
Cardiomo
by Cardiomo, Inc.

AI Verdict

Huxley SANSA and Cardiomo are adjacent competitors, both offering AI-powered wearable patches for remote cardiac monitoring. Huxley SANSA specifically targets home sleep apnea and cardiac arrhythmia diagnosis with an app-free workflow, while Cardiomo focuses on continuous heart health monitoring, including a broader range of cardiovascular events and fall detection, utilizing a mobile app for user interaction.

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if your primary need is a streamlined, app-free solution for diagnosing both sleep apnea and cardiac arrhythmias with minimal patient interaction. Its multi-day monitoring and comprehensive physiological data channels make it ideal for situations requiring detailed, yet unobtrusive, home-based cardiosleep diagnostics. The built-in cellular upload simplifies data transfer, making it suitable for patients who may struggle with smartphone applications.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Choose Cardiomo if…

Choose Cardiomo if your focus is on continuous, long-term remote monitoring of general heart health and the early detection of cardiovascular diseases with real-time alerts. Its emphasis on continuous vital sign monitoring, AI-powered disease detection, and immediate notifications to users and caregivers makes it particularly well-suited for managing chronic cardiac conditions and providing proactive care, especially for vulnerable populations like geriatrics.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Huxley SANSA Home Sleep Apnea Test (1000-00) Cardiomo
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based algorithm with cellular data upload from device Cloud-based with wearable device and mobile app
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA offers an app-free workflow with built-in cellular data upload, simplifying the patient experience by removing the need for a smartphone, Bluetooth pairing, or managing an app. In contrast, Cardiomo requires a mobile application for data transmission and alerts, which could be a barrier for some users, particularly the elderly.

Clinical Value

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA is FDA-cleared for home sleep apnea and cardiac arrhythmia diagnosis, and its diagnostic performance for OSA has been validated against polysomnography in a multicenter study. While Cardiomo is described as a medical-grade device with AI-powered disease detection and real-time alerts, it was still undergoing FDA approval as of December 2023.

Pricing & Value

Tie

Both tools require contacting the company for current pricing, making a direct comparison difficult. Cardiomo previously offered a device for $200 with a $10 monthly subscription, but current pricing is not publicly available. Without transparent pricing for either, it's impossible to determine which offers better value.

Enterprise Readiness

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA's app-free and cellular-enabled design, along with its 'SANSA GO' and 'SANSA 360' service models, suggest a streamlined workflow for healthcare providers, reducing logistical burdens like cleaning, downloading, and battery management. Cardiomo's reliance on a mobile app and Bluetooth for data transfer might introduce more variables for enterprise-level deployment and patient management.

Innovation

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA stands out with its single-patch, app-free, cellular-enabled design that simultaneously assesses obstructive sleep apnea, central sleep apnea, and ECG, offering a multi-diagnostic potential. While Cardiomo also uses an AI-powered wearable patch for continuous monitoring and disease detection, Huxley SANSA's integration of both sleep apnea and cardiac arrhythmia diagnosis in an app-free workflow represents a more novel approach to simplifying complex diagnostics.

Support & Docs

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley Medical explicitly states that SANSA provides 24/7/365 setup and FAQ support and offers online support and a customer service team for assistance. Cardiomo mentions sending notifications to users and caregivers and having a mobile app, but detailed information about their support and documentation for healthcare providers or end-users is less readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Huxley SANSA Home Sleep Apnea Test (1000-00) Cardiomo
Name Huxley SANSA Home Sleep Apnea Test (1000-00) Cardiomo
Description Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis, offering an app-free, cellular-enabled solution for streamlined patient care. Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Company Huxley Medical Cardiomo, Inc.
Tagline Streamlining cardiosleep diagnosis straight from the chest. A medical-grade wearable device that monitors vital signs and uses an AI engine to detect cardiovascular diseases and provide life-saving alerts.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Features Wearable chest patch design, App-free workflow, Built-in cellular data upload, AI-powered auto-scoring algorithms, 9 physiological data channels (ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging), Multi-day monitoring capability, Comfortable and non-invasive, Validated against polysomnography (PSG) Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)

Videos

Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Huxley SANSA offers seamless EHR integration, allowing physicians to order tests and receive reports directly through their EHR system, which can streamline workflows for sleep medicine, cardiology, and primary care. Cardiomo's platform collects vital signs and analyzes data using AI in a cloud, and while it provides real-time data and alerts, the depth of its EHR integration for direct ordering and reporting isn't explicitly detailed, though cardiology EHRs generally support integration with wearable cardiac monitoring devices.
Huxley SANSA has demonstrated high accuracy in detecting sleep apnea, with 88% sensitivity and 87% specificity for moderate-to-severe OSA, and 100% sensitivity and 99% specificity for central sleep apnea (CSA). Cardiomo claims 99.2% clinical accuracy, validated through studies, for its continuous vital sign monitoring and AI-powered disease detection, with wearable ECG devices generally showing over 90% sensitivity and specificity for common arrhythmias.
Huxley SANSA is designed for ease of use with an app-free workflow and cellular data upload, simplifying patient setup and data collection for providers. Its Holter monitor-like design may also be familiar to cardiologists and primary care physicians. Cardiomo also uses a wearable patch and mobile app, aiming for a user-friendly experience, but specific details on physician learning curve or training resources are not provided.
Huxley Medical offers 24/7/365 patient support for SANSA, and can ship the device directly to patients, which can reduce administrative burden for clinics and potentially accelerate time-to-value by streamlining the testing process. Cardiomo provides instant notifications to patients, relatives, and care providers, and aims to reduce high costs and improve health outcomes through real-time data and analysis for doctors online, suggesting a focus on timely intervention.
While both tools are HIPAA compliant, a robust security posture beyond HIPAA typically involves measures like Zero Trust Architecture, strong Cloud Security Posture Management, regular penetration testing, and encryption of data at rest and in transit. Cardiomo mentions ISO 13485 and ISO 27001 certifications, indicating adherence to quality management and information security standards. Huxley Medical's SANSA underwent cybersecurity testing in accordance with FDA guidance.
Huxley SANSA's cloud-native platform provides secure, HIPAA-compliant data access, and generally, robust healthcare IT systems, especially those integrating with EHRs, maintain detailed audit trails to log user activities and data access for security and regulatory compliance. Cardiomo's platform also operates with HIPAA-compliant cloud analytics, and medical-grade monitoring solutions typically incorporate audit trails to ensure data integrity and accountability.
Huxley SANSA offers workflow flexibility with both direct-to-patient shipping and point-of-care enrollment models, which can facilitate multi-site rollouts by adapting to different clinic operations. Cardiomo's cloud-based platform and mobile application inherently support remote monitoring, which can be beneficial for multi-site deployments by centralizing data and alerts, though specific multi-site rollout features are not detailed.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Huxley SANSA Home Sleep Apnea Test (1000-00) or Cardiomo

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.